HeartSciences (HSCS) Change in Account Payables (2021 - 2026)
HeartSciences (HSCS) posted quarterly Change in Account Payables of -$92400.0 for Q2 2026, down 6.93% year-on-year from -$99275.7 in Q2 2025, and down 370.45% on a QoQ basis from $34165.0 in Q4 2025.
HeartSciences (HSCS) Change in Account Payables (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Change in Account Payables for 6 consecutive years, with -$92400.0 the latest figure, recorded in Q2 2026.
- Quarterly Change in Account Payables fell 6.93% year-over-year to -$92400.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$180086.0 (down 39.04% YoY) and the FY2026 annual result came in at -$334.0, up 99.74% from the prior year.
- Change in Account Payables declined to -$92400.0 in Q2 2026 per HSCS's latest filing, from $34165.0 in the prior quarter.
- Over the last five years, Change in Account Payables for HSCS reached as high as $633457.0 in Q4 2023 and fell as low as -$673221.0 in Q1 2024.
- A 5-year average of -$5888.4 and a median of -$35436.0 in 2025 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables jumped 970.47% — and 2024, when it plunged 374.31%.
- Year by year, Change in Account Payables stood at $339522.0 in 2022, then jumped by 86.57% to $633457.0 in 2023, then plunged by 118.89% to -$119658.0 in 2024, then jumped by 128.55% to $34165.0 in 2025, then slumped by 370.45% to -$92400.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$92400.0, $34165.0, and -$35436.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - | -92,400.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -92,400.00 |
| Apr 30, 2026 | -92,400.00 |
| Oct 31, 2025 | 34,165.00 |
| Oct 31, 2025 | 34,165.00 |
| Jul 31, 2025 | -35,436.00 |
| Jul 31, 2025 | -35,436.00 |
| Apr 30, 2025 | -86,415.00 |
| Apr 30, 2025 | -86,415.00 |
| Jan 31, 2025 | 128,228.00 |
| Jan 31, 2025 | 128,228.00 |
| Oct 31, 2024 | -119,658.00 |
| Oct 31, 2024 | -119,658.00 |
| Jul 31, 2024 | -51,677.00 |
| Jul 31, 2024 | -51,677.00 |
| Apr 30, 2024 | 33,107.00 |
| Apr 30, 2024 | 33,107.00 |
| Jan 31, 2024 | -673,221.00 |
| Jan 31, 2024 | -673,221.00 |
| Oct 31, 2023 | 633,457.00 |
| Oct 31, 2023 | 633,457.00 |